This in-depth interview with AIRnet President William Lazonick by Marie Carpenter and Mustafa Erdem Sakinç, published in the esteemed journal Revue de la régulation, explores his extensive contributions to the field of economics. From his early research on the British…
Tag: William Lazonick
The British Academy Conference on “Resolving Global Vaccine Inequity: Innovation, Capabilities and Governance” co-organized by SOAS and AIRNET
On April 11-12, 2024, SOAS University of London and the Academic-Industry Research Network, co-hosted the British Academy Conference on “Resolving Global Vaccine Inequity: Innovation, Capabilities and Governance” to gather biomedical and social scientists, public health practitioners, and policy makers to…
Business Insider quotes and cites AIRnet research on Boeing’s stock buybacks.
Business Insider quotes and cites President of AIRnet Bill Lazonick’s INET-funded research on Boeing’s stock buybacks. The article is also cross-posted in MSN, Yahoo Finance, Business News, AOL, News Break, Star News, and Web Today.
Creating value or extracting it? An existential question.
In her blog “Thought Sparks“, Rita McGrath quotes and cites Lazonick’s book, Investing in Innovation: Confronting Predatory Value Extraction in the U.S. Corporation, and discuses “a board and governance level issue that doesn’t get nearly enough attention is whether firms…
Investing in Innovation
Confronting Predatory Value Extraction in the U.S. Corporation by William Lazonick Business corporations interact with household units and government agencies to make investments in productive capabilities required to generate innovative goods and services. When they work harmoniously, these three types…
Sick with “Shareholder Value”: US Pharma’s Financialized Business Model During the Pandemic
by William Lazonick and Öner Tulum On August 16, 2022, Congress passed the Inflation Reduction Act, which, among other things, enables Medicare to negotiate the prices of certain high-cost prescription drugs, beginning in 2026.[1] Even though it is just one…
# 12. Who controls the supply of COVID-19 vaccines, and why does it matter?
by Öner Tulum, William Lazonick, Ken Jacobson, and Ellen Chappelka Nine months after the US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the first of…
#11. Help Wanted: Biomanufacturing workers needed for COVID-19 vaccines
by Ellen Chappelka, William Lazonick, and Ken Jacobson At the beginning of May 2021, it was reported that millions of doses of the Johnson & Johnson COVID…
#10. Scaling of COVID vaccine manufacturing: Dose selection, stability, and optimization of mRNA-based COVID vaccines
by Öner Tulum, William Lazonick, and Ken Jacobson This is the final installment of a three-part series on the scalability of mRNA vaccine production. The current article focuses…
#9. Scaling of COVID vaccine manufacturing: Procuring lipids and assembling lipid nanoparticles
by Öner Tulum, William Lazonick, and Ken Jacobson This is the second installment of a three-part series on the scalability of mRNA vaccine production. The current article focuses…
